| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | CTXI|C-telopeptide of Collagen alpha-1|I chain |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target |
Background
mouse CTXI (Cross Linked C-telopeptide of Type I Collagen) is a molecular target commonly studied in signal transduction, cancer, and immunology research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of CTXI is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of CTXI can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
CTXI (Cross Linked C-telopeptide of Type I Collagen) may also be referenced as CTXI, C-telopeptide of Collagen alpha-1, and I chain in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how CTXI relates to tumor microenvironment biology, cell proliferation and apoptosis, metastasis and invasion pathways, and angiogenesis and immune-oncology mechanisms in signal transduction, cancer, and immunology research.
- Interpreting shifts in CTXI levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
CTXI has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with signal transduction, cancer, and immunology studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Undercarboxylated OCN Inhibits Chondrocyte Hypertrophy and Osteoarthritis Development through GPRC6A/HIF-1α Cascade
IF: 10 Journal: International Journal of Biological Sciences Author: Beijing Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, P.R. China. Cited Date: 2025-07-18
3′-Sialyllactose alleviates bone loss by regulating bone homeostasis
IF: 5.9 Journal: Communications Biology Author: Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea Cited Date: 2024-03-08
Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling
IF: 5.753 Journal: Cell Proliferation Cited Date: 2020-09-01
Bone-targeting AAV-mediated gene silencing in osteoclasts for osteoporosis therapy
IF: 4.875 Journal: Methods & Clinical Development Cited Date: 2020-04-17
Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency
IF: 4.289 Journal: Journal of Leukocyte Biology Cited Date: 2019-07-16
Evaluation of anti-osteoporotic activity of butanolic fraction from Passiflora foetida in ovariectomy-induced bone loss in mice
IF: 2.326 Journal: Biomedicine & Pharmacotherapy Cited Date: 2017-04-17